Habraken JB[au] - Search Results

Year	Number of Results
1993	1
1996	1
1998	2
1999	1
2000	2
2001	4
2002	2
2003	1
2004	3
2005	2
2006	1
2007	2
2008	3
2016	1
2017	2
2019	1
2020	1
2022	1
2023	0

1

Method to determine the statistical technical variability of SUV metrics.

De Luca GMR, Habraken JBA. De Luca GMR, et al. Among authors: habraken jba. EJNMMI Phys. 2022 Jun 6;9(1):40. doi: 10.1186/s40658-022-00470-2. EJNMMI Phys. 2022. PMID: 35666316 Free PMC article.

2

Optimization of injected ⁶⁸Ga-PSMA activity based on list-mode phantom data and clinical validation.

Wielaard J, Habraken JBA, Brinks P, Lavalaye J, Boellaard R. Wielaard J, et al. Among authors: habraken jba. EJNMMI Phys. 2020 Apr 15;7(1):20. doi: 10.1186/s40658-020-00289-9. EJNMMI Phys. 2020. PMID: 32297142 Free PMC article.

3

Measuring the actual I-131 thyroid uptake curve with a collar detector system: a feasibility study.

Brinks P, Van Gils K, Kranenborg E, Lavalaye J, Dickerscheid DBM, Habraken JBA. Brinks P, et al. Among authors: habraken jba. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):935-940. doi: 10.1007/s00259-016-3595-y. Epub 2016 Dec 17. Eur J Nucl Med Mol Imaging. 2017. PMID: 27988801

4

Validation of quantitative salivary gland scintigraphy in relation to the American-European concensus criteria for Sjögren's syndrome.

Kaldeway HP, Ter Borg EJ, van de Garde EMW, Habraken JBA, van Buul MMC. Kaldeway HP, et al. Among authors: habraken jba. Nucl Med Commun. 2019 Apr;40(4):343-348. doi: 10.1097/MNM.0000000000000983. Nucl Med Commun. 2019. PMID: 30807534

5

Identification of peak V in brainstem auditory evoked potentials with neural networks.

Habraken JB, van Gils MJ, Cluitmans PJ. Habraken JB, et al. Comput Biol Med. 1993 Sep;23(5):369-80. doi: 10.1016/0010-4825(93)90134-m. Comput Biol Med. 1993. PMID: 8222616

6

Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.

de Win MM, de Jeu RA, de Bruin K, Habraken JB, Reneman L, Booij J, den Heeten GJ. de Win MM, et al. Among authors: habraken jb. Eur Neuropsychopharmacol. 2004 May;14(3):185-9. doi: 10.1016/S0924-977X(03)00101-9. Eur Neuropsychopharmacol. 2004. PMID: 15056477

7

Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT.

Lavalaye J, Linszen DH, Booij J, Dingemans PM, Reneman L, Habraken JB, Gersons BP, van Royen EA. Lavalaye J, et al. Among authors: habraken jb. Schizophr Res. 2001 Jan 15;47(1):59-67. doi: 10.1016/s0920-9964(00)00023-2. Schizophr Res. 2001. PMID: 11163545

8

No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity.

Verberne HJ, de Bruin K, Habraken JB, Somsen GA, Eersels JL, Moet F, Booij J, van Eck-Smit BL. Verberne HJ, et al. Among authors: habraken jb. Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):483-90. doi: 10.1007/s00259-005-0022-1. Epub 2006 Jan 20. Eur J Nucl Med Mol Imaging. 2006. PMID: 16425032

9

MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings.

Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ. Reneman L, et al. Among authors: habraken jb. AJNR Am J Neuroradiol. 2000 Jun-Jul;21(6):1001-7. AJNR Am J Neuroradiol. 2000. PMID: 10871002 Free PMC article.

10

Evaluation of high-resolution pinhole SPECT using a small rotating animal.

Habraken JB, de Bruin K, Shehata M, Booij J, Bennink R, van Eck Smit BL, Busemann Sokole E. Habraken JB, et al. J Nucl Med. 2001 Dec;42(12):1863-9. J Nucl Med. 2001. PMID: 11752086 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results